Shandong Xinhua Pharmaceutical Company Limited reported unaudited consolidated and parent earnings results for the first quarter ended March 31, 2019. For the quarter, on consolidated basis, the company reported total operating income of RMB 1,617,765,684.10 against RMB 1,417,348,459.35 a year ago. Operating profits were RMB 100,371,244.74 against RMB 83,417,498.65 a year ago. Net profits was RMB 81,850,161.21 against RMB 69,847,828.32 a year ago. Basic and diluted earnings per share were RMB 0.12 against RMB 0.11 a year ago. For the quarter, on parent basis, the company reported total operating income of RMB 862,500,597.83 against RMB 801,008,517.76 a year ago. Operating profits were RMB 94,457,983.15 against RMB 82,415,262.91 a year ago. Net profits was RMB 79,109,004.85 against RMB 69,404,867.44 a year ago.